No Data
No Data
NeurAxis Says Proprietary PENFS Technology Officially Incorporated Into Newly Released Clinical Practice Guidelines Issued By Pediatric Academic Society For Treatment Of FAP In IBS
NeurAxis Achieves Critical Milestone; Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain (FAP) in IBS
Earnings Call Summary | Neuraxis(NRXS.US) Q1 2025 Earnings Conference
NeurAxis, Inc. Approves Key Proposals at Annual Meeting
NeurAxis, Inc. Releases Investor Presentation
NeurAxis to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
ABSOLUTELY : hey Jaguar, can I ask why this one drop while good news came out? thank you!
Jaguar8 OP ABSOLUTELY : No volume so shorts can easily attack it